HOTEL-OKURA
In a much-anticipated event and to the delight of its many followers worldwide, The Okura Tokyo , the new flagship hotel of Hotel Okura Co., Ltd , today opened its doors to the public.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190912005387/en/
The original Hotel Okura Tokyo opened in 1962 as a first-class hotel that quickly became renowned worldwide for its blending of traditional Japanese beauty with the very best in accommodation, cuisine and service. It closed its doors in August 2015, and after four years of rebuilding work, it reopened today as The Okura Tokyo.
Masaharu Naruse, President and Representative Director, Hotel Okura Tokyo Co., Ltd., said, “I’m proud to present our new flagship property, The Okura Tokyo. Fully embodying one of Okura’s key philosophies—offering “the Best A.C.S.”, or Accommodation, Cuisine and Services—we are committed to honoring our pedigree while endeavoring to further refine this philosophy so that the hotel will once again be treasured by people from all over the world.”
The Okura Tokyo is the highest-branded property of the Hotel Okura group. It reprises the former Hotel Okura Tokyo’s famed traditional Japanese beauty as well as its cherished simplicity and elegance to offer a new combination of “traditional luxury – The Okura Heritage” and “contemporary luxury – The Okura Prestige.” The creation of two separate properties reflects the company’s strategy to evolve its room branding into two differentiated categories.
A total of 508 luxury rooms are available in two buildings on the spacious central-Tokyo Okura property, about half of which—1.3 hectares—is covered with lush gardens and greenery. The Okura Museum of Art is also located on the property.
The smaller of the two buildings, The Okura Heritage Wing, which has its own reception, is a 75-meter, 17-story structure with refreshing views of gardens and greenery on three sides. The spacious guest rooms in The Okura Heritage Wing offer generous floor areas of 60m2 with broad 8m widths. The Okura Heritage Wing is a top-end luxury hotel with a tasteful, classically Japanese atmosphere. The beloved Yamazato Japanese restaurant is making its much-awaited return here, as is the renowned Chosho-an tea ceremony room, making the Okura Heritage Wing the perfect choice for special gatherings in elegant Japanese settings.
The larger Okura Prestige Tower is a 188-meter, 41-story structure combining premium quality accented with refined Japanese aesthetics. Guest rooms begin on the 28th floor; standard-size rooms measuring some 50m2 afford vistas of the Tokyo metropolis from expansive windows. On the top floor of The Okura Prestige Tower, guests can take in fabulous views of the city while dining at historic Sazanka, the hotel’s reborn teppanyaki restaurant. Additionally, an all-day dining restaurant, Orchid, features a mix of cuisine with relaxing indoor and outdoor seating, and Toh-Ka-Lin offers delicious Chinese cuisine.
The Okura Prestige Tower is equipped with substantial banquet facilities, including one of the largest ballrooms of any hotel in Tokyo, immediately establishing The Okura Tokyo as a premier venue for prestigious international conferences. The Okura Prestige Tower will offer access to the Okura Fitness & Spa for exercise and relaxation against the backdrop of panoramic views of Tokyo on the 26th and 27th floors.
The Okura Museum of Art, originally established in 1917 as Japan’s first privately operated art museum, will once again attract art lovers from the world over with a celebrated collection that includes some 2,500 works of art, among which are three National Treasures, 13 Important Cultural Properties and 44 Important Art Objects designated by the Japanese government.
Reconstruction has changed the appearance of the hotel; however, many of the ornaments which decorated the original main building now adorn The Okura Tokyo. After the end of August 2015 when the hotel ceased operations and the main lobby was tentatively closed, a one week period was secured prior to the commencement of dismantling to allow examination and measurement of the existing artefacts and decorations.
Legacy decorations from the original hotel grace the new lobby of The Okura Prestige Tower, including the distinctive hexagonal Okura Lantern ceiling lights, lacquered tables and chairs arranged like plum flowers, and the world map and clock displaying global time zones. A number of other decorations have been faithfully reproduced for the new lobby. These include the Four Petal Flowers wall tapestry, a Nishijin brocade originally designed by Japanese “human national treasure” Kenkichi Tomimoto, and shoji paper windows with Asanoha-mon leaf-pattern lattice work.
The lobbies of The Okura Prestige Tower have been designed by Yoshio Taniguchi, celebrated architect of the redesigned Museum of Modern Art in New York and son of Yoshiro Taniguchi, designer of the Hotel Okura Tokyo’s famous lobby, a further nod to the Okura legacy.
Commented Yoshio Taniguchi, “The original lobby designed by my father, Yoshiro Taniguchi, was extremely popular, so I was honored to have been asked to redesign the new main lobby of the Okura Tokyo, at the same time feeling a sense of destiny and responsibility. It was a challenge to not only re-create the old main lobby but to turn it into something even more wonderful, and I hope that the new main lobby will be beloved by all guests and visitors to the Okura Tokyo for many years to come. There are various types of memorable lobbies, including those whose feel and aura have evolved over time; the new Okura Tokyo lobby is one that is reminiscent of the time of the opening of the original hotel more than half a century ago but which can similarly be expected to refresh itself over time.”
The Heian Room will accommodate up to 2,000 people, making it one of Tokyo’s largest ballrooms. Motifs from the Collection of Ancient and Modern Japanese Poems, a national treasure, will decorate the walls. The room will also boast a first-class audio visual system.
Small artistic displays entitled “Takumi of Japan” are located on all guest room floors of the Okura Prestige Tower, showcasing carefully selected traditional handcrafts from all 47 prefectures in Japan.
The top two guest floors of The Okura Prestige Tower—the 39th and 40th floors—comprise an unprecedented duplex suite comprising a 730-square meter living space with three bedrooms – Japan’s largest hotel suite. With its two-story-ceiling living room and event-ready theater, the luxurious suite will also be an exceptional venue for one-of-a-kind meetings. Additionally, the bathroom of the master bedroom will feature a Ne-Yu bed bath and Utase-Yu waterfall bath for supreme relaxation.
About Hotel Okura Co., Ltd.
Hotel Okura Co., Ltd. , founded in 1958, opened its flagship Hotel Okura Tokyo in 1962. Hotel Okura has extensive expertise in the hospitality world, including asset ownership and hotel development, as well as hotel management, restaurant business and chain operations through its subsidiaries and other group companies. The brand unites member hotels under its “Best Accommodation, Cuisine and Service” philosophy to ensure that all guests enjoy Okura’s signature hospitality, which combines Japanese attention to detail and Western functionality. The subsidiary Okura Nikko Hotel Management Co., Ltd. operates 72 properties (47 in Japan and 25 overseas) encompassing some 22,666 guest rooms (as of September 12, 2019) under three hotel groups: Okura Hotels & Resorts , Nikko Hotels International and Hotel JAL City .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190912005387/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aspect Announces CEO Leadership Transition and New Independent Board7.1.2026 00:13:00 CET | Press release
Aspect, a leading provider of cloud-based workforce management solutions, has announced a leadership transition, including the appointment of Jeff Kupietzky as Interim Chief Executive Officer and the formation of a new independent Board of Directors, marking an important next chapter for the company. As part of this transition, Darryl Kelly will step down as Chief Executive Officer and transition into a Strategic Advisor role, effective January 1, 2026. Darryl led Aspect through a pivotal period of transformation, helping reposition the business, refine its vision, and reinvigorate its innovation and execution. The company and its stakeholders thank Darryl for his leadership and contributions during a period of meaningful change. With Darryl continuing as Strategic Advisor, the organization retains continuity for employees, customers, and stakeholders. “Aspect is starting a new season, building upon the strong foundation we’ve created together,” said Darryl Kelly. “This transition is a
Brenus Pharma Reports Favorable Tolerability and Clinical Signals in Early Preliminary Results of First-In-Human Study for STC-1010 in Unresectable Metastatic Stage Colorectal Cancer (MSS CRC) Patients6.1.2026 21:00:00 CET | Press release
Brenus Pharma, a clinical stage biotechnology company unlocking the immune system in vivo to fight solid tumors, announced the successful completion of the first dose levels in its ongoing first-in-human study. The multi-center, open-label trial (NCT06934538) is a phase Ia/Ib study designed to evaluate safety, tolerability and preliminary clinical activity of STC-10101 in a first line setting. It will include in vivo analysis of immune and tumor dynamics during dose escalation of treatment and cohort extension to patients with unresectable locally advanced (stage IIIC, T4b) or unresectable metastatic (stage IV) MSS2 colorectal cancer (CRC). Early findings indicate that the first dose levels have been successfully completed with good overall tolerance and no-dose-limiting toxicities observed to date. “We are pleased to report that the safety profile observed to date is good and consistent with our expectations with no DLT,” said Paul Bravetti, CEO of Brenus Pharma. “Moreover, preliminar
SPIE, the International Society for Optics and Photonics, Announces Its 2026 Fellows6.1.2026 20:35:00 CET | Press release
The Society is welcoming 40 new Fellow Members from across the globe SPIE, the international society for optics and photonics, welcomes 40 Members as new Fellows of the Society in the 2026 cohort. They join their Fellow Member colleagues in being honored for their excellent technical achievements, as well as for their substantial service to the optics and photonics community and to SPIE. Fellows are Members of the Society who have made significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and imaging. Since the Society's inception in 1955, more than 1,800 SPIE Members have become Fellows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106630672/en/ SPIE, the international society for optics and photonics, announces its 2026 Fellows This year’s inductees are high-profile leaders in academia, industry, and government, many of whom are particularly prominent in their support
Chemelex Adds Electric Heat Trace Group Ltd.’s SmartTrace Monitoring Platform to its Heat Tracing Portfolio6.1.2026 20:00:00 CET | Press release
Chemelex, a global leader in electric thermal and sensing solutions, today announced the successful completion of its acquisition of substantially all the assets and ongoing operations of Electric Heat Trace Group Ltd. (EHT Group), headquartered in Ontario, Canada. This strategic move marks an exciting start to the new year and reinforces Chemelex’s commitment to delivering smarter, data-driven solutions for industrial heat trace systems. EHT Group is a recognized innovator in heat trace management, offering advanced software, integrated controller solutions, wireless communication modules, and comprehensive field services. Its flagship platform, SmartTrace, is a robust solution available in both cloud-based and on-premises deployments that enables predictive maintenance, minimizes downtime, and provides secure remote monitoring—helping customers achieve greater reliability and operational efficiency. This endeavor will help Chemelex support greater operational efficiencies for our cus
ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA6.1.2026 19:30:00 CET | Press release
Combination therapy showed compelling survival and disease control compared to current standard, regardless of PD-L1 statusHigh GEA burden in Asia, where BeOne holds ZIIHERA rights, signals potential broad patient impactResults to be presented as a Late-Breaking Abstract Oral Presentation at ASCO GI on January 8, 2026 BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced full results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), a HER2-targeted bispecific antibody, in combination with chemotherapy, with and without PD-1 inhibitor TEVIMBRA® (tislelizumab), as a first-line treatment for HER2-positive (HER2+) locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). These data, including the first interim overall survival (OS) analysis, will be presented as a Late-Breaking Abstract Oral Presentation (#LBA285) at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) on
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
